Literature DB >> 19351866

Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.

Patrick J Shaw1, Patricia E Ganey, Robert A Roth.   

Abstract

Trovafloxacin (TVX), a fluoroquinolone antibiotic, has been strongly linked with several cases of idiosyncratic hepatotoxicity in humans. Previous studies showed that a modest inflammatory stress induced by a Gram-negative bacterial stimulus [i.e., lipopolysaccharide (LPS)] rendered nontoxic doses of TVX hepatotoxic in mice. This study compared the interaction of TVX with Gram-negative and Gram-positive stimuli. Mice were given TVX 3 h before LPS (Gram-negative stimulus) or a peptidoglycan-lipoteichoic acid (PGN-LTA) mixture isolated from Staphylococcus aureus (Gram-positive stimulus). Administration of TVX, LPS, or PGN-LTA alone was nonhepatotoxic. However, TVX administration before PGN-LTA or LPS resulted in significant liver injury that occurred with similar time courses. TVX/PGN-LTA-induced hepatocellular necrosis was primarily localized to centrilobular regions, whereas that caused by TVX/LPS was predominantly midzonal. Administration of either LPS or PGN-LTA alone led to increased plasma concentrations of several cytokines and chemokines at a time near the onset of liver injury. TVX administration before LPS enhanced the concentrations of all of these cytokines, whereas TVX treatment before PGN-LTA increased all of the cytokines except tumor necrosis factor (TNF)-alpha and interferon-gamma. Liver injury was reduced in TVX/LPS- and TVX/PGN-LTA-treated mice given an antibody to CD18 and also in mice deficient in neutrophil [polymorphonuclear neutrophil (PMN)] elastase. Hepatic PMN accumulation and TNF-alpha production after TVX/PGN-LTA-, but not after TVX/LPS-coexposure, was CD18-dependent. In summary, TVX significantly enhanced the murine inflammatory response to either a Gram-negative or a Gram-positive stimulus and caused hepatotoxicity that developed similarly and was dependent on PMN activation in mice but that differed in lesion location and cytokine profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351866      PMCID: PMC2700160          DOI: 10.1124/jpet.109.151068

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  34 in total

Review 1.  Innate sensors for Gram-positive bacteria.

Authors:  Joerg R Weber; Philippe Moreillon; Elaine I Tuomanen
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

Review 2.  Role of Toll-like receptors in pathogen recognition.

Authors:  S Janssens; R Beyaert
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  Role of neutrophils in the synergistic liver injury from monocrotaline and bacterial lipopolysaccharide exposure.

Authors:  Steven B Yee; Umesh M Hanumegowda; Jon A Hotchkiss; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2003-03       Impact factor: 4.849

4.  Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

Review 5.  Initial responses to endotoxins and Gram-negative bacteria.

Authors:  Didier Heumann; Thierry Roger
Journal:  Clin Chim Acta       Date:  2002-09       Impact factor: 3.786

Review 6.  Regulation of dendritic cell function through Toll-like receptors.

Authors:  Tsuneyasu Kaisho; Shizuo Akira
Journal:  Curr Mol Med       Date:  2003-06       Impact factor: 2.222

7.  Clinical toxicological aspects of fluoroquinolones.

Authors:  Ralf Stahlmann
Journal:  Toxicol Lett       Date:  2002-02-28       Impact factor: 4.372

8.  Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.

Authors:  Patrick J Shaw; Amy C Ditewig; Jeffrey F Waring; Michael J Liguori; Eric A Blomme; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2008-10-16       Impact factor: 4.849

9.  Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytes.

Authors:  P A Majcherczyk; E Rubli; D Heumann; M P Glauser; P Moreillon
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 10.  Proinflammatory activity of cell-wall constituents from gram-positive bacteria.

Authors:  P Moreillon; P A Majcherczyk
Journal:  Scand J Infect Dis       Date:  2003
View more
  16 in total

Review 1.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

2.  Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice.

Authors:  Adarsh Gandhi; Tao Guo; Pranav Shah; Bhagavatula Moorthy; Romi Ghose
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

3.  An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.

Authors:  Shingo Oda; Yuka Uchida; Michael D Aleo; Petra H Koza-Taylor; Yusuke Matsui; Masanori Hizue; Lisa D Marroquin; Jessica Whritenour; Eri Uchida; Tsuyoshi Yokoi
Journal:  Arch Toxicol       Date:  2020-08-20       Impact factor: 5.153

4.  2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury.

Authors:  Aaron M Fullerton; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-16       Impact factor: 4.219

5.  Hypoxia sensitization of hepatocytes to neutrophil elastase-mediated cell death depends on MAPKs and HIF-1α.

Authors:  Erica M Sparkenbaugh; Patricia E Ganey; Robert A Roth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-05       Impact factor: 4.052

Review 6.  Beyond Metabolism: Role of the Immune System in Hepatic Toxicity.

Authors:  Kenneth L Hastings; Martin D Green; Bin Gao; Patricia E Ganey; Robert A Roth; Gary R Burleson
Journal:  Int J Toxicol       Date:  2020 Mar/Apr       Impact factor: 2.032

7.  Roles of the hemostatic system and neutrophils in liver injury from co-exposure to amiodarone and lipopolysaccharide.

Authors:  Jingtao Lu; Robert A Roth; Ernst Malle; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2013-08-02       Impact factor: 4.849

8.  Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.

Authors:  Patrick J Shaw; Amy C Ditewig; Jeffrey F Waring; Michael J Liguori; Eric A Blomme; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2008-10-16       Impact factor: 4.849

Review 9.  Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.

Authors:  Xiaomin Deng; James P Luyendyk; Patricia E Ganey; Robert A Roth
Journal:  Pharmacol Rev       Date:  2009-09       Impact factor: 25.468

10.  Current challenges and controversies in drug-induced liver injury.

Authors:  Alberto Corsini; Patricia Ganey; Cynthia Ju; Neil Kaplowitz; Dominique Pessayre; Robert Roth; Paul B Watkins; Mudher Albassam; Baolian Liu; Saray Stancic; Laura Suter; Michele Bortolini
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.